Clinical evaluation and management of drug hypersensitivity

Immunology and Allergy Clinics of North America

Volumn 24, Issue 3, 2004, Pages 357-371

  Volcheck, Gerald W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BETA LACTAM; CEPHALOSPORIN; CIPROFLOXACIN; CORTICOSTEROID; DIPHENHYDRAMINE; ENZYME; HEPARIN; HYPERTENSIVE FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INSULIN; LATEX; LOCAL ANESTHETIC AGENT; METHYLDOPA; NEUROMUSCULAR BLOCKING AGENT; OKT 3; PENICILLIN G; PREDNISONE; PROTAMINE; QUINIDINE; RANITIDINE; THIOBARBITURIC ACID; TRIMETHOPRIM; TRYPTASE;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLISTER; BONE MARROW DEPRESSION; BULLOUS SKIN DISEASE; BURN; COMPRESSION THERAPY; CYTOTOXICITY; DESENSITIZATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SCREENING; EDEMA; ERYTHEMA; ERYTHEMA MULTIFORME; FEVER; GRANULOCYTOPENIA; HISTORY; HUMAN; HUMORAL IMMUNITY; IMMEDIATE TYPE HYPERSENSITIVITY; INFLAMMATION; MAST CELL; NUTRITION; PAPULE; PHYSICAL EXAMINATION; PRICK TEST; PRIORITY JOURNAL; PRURITUS; REVIEW; SERUM SICKNESS; SKIN ALLERGY; SKIN CARE; SKIN TEST; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA;

ANTIBODY FORMATION; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; HUMANS; IMMUNITY, CELLULAR; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION;

EID: 3042745261     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2004.03.003     Document Type: Review

References (30)

1. Gruchalla R.S. Drug allergy. J Allergy Clin Immunol. 111:2003;S548-S559
2. Bigby M., Jick S., Jick H., et al. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15, 438 consecutive inpatients, 1975-1983. JAMA. 256:1986;3358-3363
3. Lang D.M., Alpern M.B., Visintainer P.F., Smith S.T. Gender risk for anaphylactoid reaction to radiographic contrast media. J Allergy Clin Immunol. 95:1995;813-817
4. Bernstein D.I., Gallagher J.S., Ulmer A., Bernstein I.L. Prospective evaluation of chymopapain sensitivity in patients undergoing chemonucleolysis. J Allergy Clin Immunol. 76:1985;458-465
5. Witten D.M. Reactions to urographic contrast media. JAMA. 231:1975;974-977
6. Douglas D.M., Sukenick E., Andrade W.P., et al. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol. 93:1994;977-985
7. de Weck A.L. Pharmacologic and immunochemical mechanisms of drug hypersensitivity. Immunol Allergy Clin North Am. 11:1991;461-474
8. Neugut A., Ghatak A., Miller R. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 161:2001;15-21
9. Schwartz L.B., Yunginger J.W., Miller J., et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest. 83:1989;1551-1555
10. Valyasevi M.A., Van Dellen R.G. Frequency of systemic reactions to penicillin skin tests. Ann Allergy Asthma Immunol. 85:2000;363-365
11. Solley G.O., Gleich G.J., Van Dellen R.G. Penicillin allergy: clinical experience with a battery of skin test reagents. J Allergy Clin Immunol. 69:1982;238-244
12. Simons P.R., Roberts J.R., Gu X., et al. Epinephrine absorption in children with history of anaphylaxis. J Allergy Clin Immunol. 101:1998;33-37
13. Lawley T.J., Bielory L., Gascon P., Yancey K.B., Young N.S., Frank M.M. A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med. 311:1984;1407-1413
14. Kearns G.I., Wheeler J.G., Childress S.H., Letzig L.G. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual sensitivity. J Pediatr. 125:1994;805-811
15. Weiner M., Bernstein I.L. Allergic reactions: other addition products. Adverse reactions to drug formulation agents, a handbook of excipients. 1989;283-340 Marcel Dekker, New York
16. Padovan E., Mauri-Hellweg D., Pichler W., et al. T cell recognition of penicillin G: structural features determining antigenic specificity. Eur J Immunol. 26:1996;42-48
17. Von Greyerz S., Zanni M., Frutig K., et al. Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha/beta T cell clones. J Immunol. 162:1999;595-602
18. Romano A., Quaratino D., Di Fonso M., et al. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol. 103:1999;1186-1190
19. Tonneson M.G., Soter N.A. Erythema multiforme. J Am Acad Dermatol. 1:1979;357
20. Dahl M. Urticaria, angioedema and erythema multiforme. Clinical immunodermatology. 3rd edition:1996;327-329 Mosby, St. Louis
21. Roujeau J.C., Kelly J.P., Naldi L., et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 333:1995;1600-1607
22. Rasmussen J.E. Erythema multiforme in children: response to treatment with systemic corticosteroids. Br J Dermatol. 95:1976;181-185
23. Patterson R., Grammer L.C., et al. Stevens-Johnson syndrome (SJS): effectiveness of corticosteroids in management and recurrent SJS. Allergy Proc. 13:1992;89-95
24. Peters W., Zaidi J., et al. Toxic epidermal necrolysis: a burn-centre challenge. Can Med Assoc J. 144:1991;1477-1480
25. Habif T.B. Hypersensitivity syndromes and vasculitis. Clinical dermatology. 3rd edition:1996;566-596 Mosby, St. Louis
26. Viard I., Wehrli P., Bullani R., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282:1998;490-493
27. Stella M., Cassano P., Bollero D., Clemente A., Giorio G. Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience. Dermatology. 203:2001;45-49
28. Greenburger P.A., Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol. 87:1991;867
29. Tas S., Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology. 206:2003;353-356
30. Chopra S., Levell N.J., Cowley G., Gilkes J.J.H. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol. 134:1996;1109-1112